Aim: To examine the burden of respiratory symptoms, quality of life and co-morbid illness in
COPD patients receiving maintenance treatment in a real world setting. Methods: In a single …

Background Interactions between spirometry and patient-reported outcomes in COPD are
not well understood. This systematic review and study-level analysis investigated the …

It has been shown that patients with chronic obstructive pulmonary disease (COPD) develop
dynamic hyperinflation (DH), which contributes to dyspnoea and exercise intolerance …

Long-acting bronchodilators in combination with inhaled corticosteroids (ICS) are
recommended to decrease the risk of recurrent exacerbations in patients with Global …

This review summarizes the long-term clinical outcomes associated with β-agonist and
anticholinergic bronchodilator use in patients with chronic obstructive pulmonary disease …

Objective The GOLD guidelines suggest that the presence of a post-bronchodilator forced
expiratory volume in one second (FEV1)< 80% of the predicted value in combination with a …

Expiratory airway collapse is a characteristic feature in patients with chronic obstructive
pulmonary disease (COPD). We hypothesized that this collapse might mask the effects of …

The most recent guidelines define COPD in a multidimensional way, nevertheless the
diagnosis is still linked to the limitation of airflow, usually measured by the reduction in the …

The cardiovascular risk of concurrently using long-acting β2-agonists (LABAs) and
anticholinergics (LAMAs) in COPD is uncertain. We assessed the comparative …

Introduction This study aimed to characterize patients with chronic obstructive pulmonary
disease (COPD) newly prescribed a long-acting bronchodilator (LABD), and to assess …